e-learning
resources
ERS Research Seminars
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New possibilities in exposure assessment for microbial agents
Dick Heederik (Utrecht, Netherlands)
Source:
ERS Research Seminar 2015
Number:
4
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dick Heederik (Utrecht, Netherlands). New possibilities in exposure assessment for microbial agents. ERS Research Seminar 2015
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Related content which might interest you:
New therapeutic targets
Source: Annual Congress 2007 - COPD – a disease of accelerated ageing?
Year: 2007
Effectiveness of different biomarkers in assessing asphalt exposure health effects
Source: Eur Respir J 2006; 28: Suppl. 50, 619s
Year: 2006
Genomics-based identification of targets in pathogenic bacteria for potential therapeutic use
Source: Annual Congress 2004 - Novel approaches to the treatment of pneumonia
Year: 2004
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
New experiences from global use of new tools in TB management and control
Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Year: 2013
New methodologogic approaches to the management of antituberculous service
Source: Eur Respir J 2003; 22: Suppl. 45, 381s
Year: 2003
Reasons for hepatotoxic reactions to chemotherapeutic agents and possibilities of their prevention in adolescents with tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 468s
Year: 2001
New enzyme immunoassays for airborne wheat allergen exposure assessment in the occupational environment: the MOCALEX project
Source: Eur Respir J 2003; 22: Suppl. 45, 489s
Year: 2003
Molecular epidemiology of adverse respiratory effects: A high-throughput screening method to detect biomarkers of genotoxic exposure
Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates
Year: 2010
New methods of the treatment efficacy evaluation at asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003
New anti-tuberculosis drugs for special populations: a difficult-to-address issue
Source: Eur Respir J 2016; 48: 957-958
Year: 2016
An integrative genomics approach identifies new asthma pathways related to air pollution exposure
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept